Topic

Dash Bio

Dash Bio Secures $11 Million for Automated Bioanalysis and Drug Discovery

Insider Brief PRESS RELEASE — Dash Bio, a preclinical and clinical bioanalysis company reinventing the speed and scalability of drug development, today announced it has raised an additional $11 million in funding, bringing its

23 Jul 2025 · 3 min read

Dash Bio

Dash Bio Secures $11 Million for Automated Bioanalysis and Drug Discovery

Trending today

Pigment Raises $250M at $2.3B Valuation

Microsoft’s AI Diagnostic System Outperforms Generalist Doctors on Complex Cases, Science Study Finds

DeepSeek Secures Reported $15B Days After U.S. Federal Ban

France Sets 2027 Autonomous Vehicle Approval Path as Stellantis, Wayve, Bolt and G7 Pitch Pilots

AuxoAI Secures $20.7M Series A to Scale the Forward-Deployed AI Company

Dash Bio

Dash Bio Secures $11 Million for Automated Bioanalysis and Drug Discovery

Trending today

Pigment Raises $250M at $2.3B Valuation

Microsoft’s AI Diagnostic System Outperforms Generalist Doctors on Complex Cases, Science Study Finds

DeepSeek Secures Reported $15B Days After U.S. Federal Ban

France Sets 2027 Autonomous Vehicle Approval Path as Stellantis, Wayve, Bolt and G7 Pitch Pilots

AuxoAI Secures $20.7M Series A to Scale the Forward-Deployed AI Company

The AI economy, every weekday morning